Incidence and mortality of sepsis, severe sepsis, and septic shock in intensive care unit patients with candidemia

Infectious Diseases

Volumn 47, Issue 8, 2015, Pages 584-587

  Ng, Kevin ^a   Schorr, Christa ^b   Reboli, Annette C ^a   Zanotti, Sergio ^b   Tsigrelis, Constantine ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b Cooper Medical School of Rowan University and Cooper University Hospital ^*  (United States)

Author keywords

Candida; incidence; intensive care; mortality; sepsis

Indexed keywords

ADULT; ARTICLE; CANDIDEMIA; CAUSE OF DEATH; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; SEPTIC SHOCK; ADOLESCENT; AGED; CANDIDA; HOSPITAL MORTALITY; INCIDENCE; ISOLATION AND PURIFICATION; LENGTH OF STAY; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; SEPSIS; SHOCK, SEPTIC; TIME FACTOR; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANDIDA; CANDIDEMIA; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84961710279     PISSN: 23744235     EISSN: None     Source Type: Journal    
DOI: 10.3109/23744235.2015.1028100     Document Type: Article

References (13)

1. Micek S, Hampton N, Doherty JA, Kumar A. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 2012 ; 54 : 1739-46.
2. Guzman JA, Tchokonte R, Sobel JD. Septic shock due to candidemia: outcomes and predictors of shock development. J Clin Med Res 2011 ; 3 : 65-71.
3. Kilgannon J H, Jones AE, Parrillo J E, Dellinger R P, Milcarek B, Hunter K, et al. Emergency Medicine Shock Research Network (EMShockNet) Investigators. Relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest. Circulation 2011 ; 123 : 2717-22.
4. Kramer A A, Higgins T L, Zimmerman J E. The association between ICU readmission rate and patient outcomes. Crit Care Med 2013 ; 41 : 24-33.
5. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003 ; 31 : 1250-6.
6. Dellinger R P, Levy M M, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013 ; 41 : 580-637.
7. Das I, Nightingale P, Patel M, Jumaa P. Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK. Int J Infect Dis 2011 ; 15 : e759-63.
8. Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, et al. Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999 ; 28 : 1071-9.
9. Patel G P, Simon D, Scheetz M, Crank C W, Lodise T, Patel N. The effect of time to antifungal therapy on mortality in Candidemia associated septic shock. Am J Ther 2009 ; 16 : 508-11.
10. Tortorano A M, Biraghi E, AstolfiA, Ossi C, Tejada M, Farina C, et al. FIMUA Candidemia Study Group. European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. JHosp Infect 2002 ; 51 : 297-304.
11. H adley S, Lee W W, Ruthazer R, Nasraway S A Jr. Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients. Crit Care Med 2002 ; 30 : 1808-14.
12. Labelle AJ, Micek ST, Roubinian N, Kollef MH. Treatmentrelated risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med 2008 ; 36 : 2967-72.
13. Bassetti M, Merelli M, Righi E, Diaz-Martin A, Rosello E M, Luzzati R, et al. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol 2013 ; 51 : 4167-72.